EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Autophagy activation ameliorates cognitive deficits and alpha-synuclein pathology in an adeno-associated viral vector mediated rat model of Lewy body disorders

Elif Cinar, Gül Yalcin-Cakmakli, Hilal Akyel, Ayse Ulusoy, Banu Cahide Tel, Bülent Elibol

Pharmacology Biochemistry and Behavior · 2025

DOI: 10.1016/j.pbb.2025.174096 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology Biochemistry and Behavior, 2025. Verfasst von Elif Cinar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Center for Neurodegenerative Disease Research, University of Pennsylvania, Perelman School of Medici…. Hauptthemen laut MEDLINE: alpha-Synuclein, Autophagy, Dependovirus, Lewy Body Disease. Die Arbeit nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Michael J. Fox Foundation for Parkinson's Research, Hacettepe University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lewy body disorders (LBD), including Parkinson's disease (PD), Parkinson's disease with dementia (PDD), and dementia with Lewy bodies (DLB), are characterized by the aggregation of alpha-synuclein (a-syn). Despite shared pathological features, these disorders have distinct clinical characteristics, in terms of both motor and cognitive symptoms. We created a unique rat model of dual-site injection of adeno-associated viral vectors carrying human a-syn (AAV5-h-a-syn) simultaneously and bilaterally into the substantia nigra and dentate gyrus, to recapitulate both nigrostriatal and hippocampal-based a-syn pathology associated with PDD and DLB. Inspired by the distinct pathological features of the model, namely the CA2-dominated accumulation of phosphorylated a-syn, in the current study we aimed to evaluate comparatively the consequences of autophagic induction on a-syn pathology in these targeted areas. This was achieved by the chronic administration of rapamycin, for 8 weeks starting 10 weeks post-AAV injections. Behavioral assessments were conducted by evaluation of locomotor activity, anxiety-related behavior, object and spatial learning and memory. Histopathological examinations involved in-depth analysis of a-syn pathology, neuronal and synaptic integrity and autophagic markers. Results demonstrated that rapamycin significantly ameliorated cognitive deficits and reduced phosphorylated a-syn accumulation, significantly in CA2 throughout all its sublayers and partially in CA3 sublayers. Despite no alteration in NeuN and TH levels, synaptophysin expressions were decreased in both the hippocampus and striatum in a-syn overexpressing animals, which were partially restored by rapamycin treatment. Intriguingly, autophagic activation, as indicated by the increased expression of beclin-1, LC3-I/II, p62, and Atg proteins, was predominantly observed in the hippocampus but not in the striatum, suggesting region-specific differential response to autophagic induction in terms of a-syn pathology. This dual-site injection model provides a valuable tool for studying a-syn-related dementia and evaluating potential restorative therapies. Our findings underscore the importance of autophagy-targeting early interventions to alleviate cognitive deficits by reducing hippocampal a-syn burden in LBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinAutophagyDependovirusLewy Body DiseaseCognitive DysfunctionAnimalsRatsMaleDisease Models, AnimalGenetic VectorsSirolimusHumansRats, Sprague-Dawley

Stichwörter der Autor:innen

Alpha-synucleinopathiesCA2DementiaHippocampusParkinson's diseaseRapamycinStratum pyramidaleSynaptic integrity

Substanzen

alpha-SynucleinSirolimus

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Center for Neurodegenerative Disease Research, University of Pennsylvania, Perelman School of Medicine, Philadelphia, USA; Department of Pharmacology, Hacettepe Universit…
  • Department of Neurology, Hacettepe University, School of Medicine, Ankara, Turkiye.
  • Department of Pharmacology, Hacettepe University, School of Pharmacy, Ankara, Turkiye; Department of Pharmacology, Baskent University, School of Pharmacy, Ankara, Turkiye.
  • German Center for Neurodegenerative Diseases, Bonn, Germany.
  • Department of Pharmacology, Hacettepe University, School of Pharmacy, Ankara, Turkiye.
  • Institute of Neurological Sciences and Psychiatry, Hacettepe University, Ankara, Turkiye.

Förderung

  • Michael J. Fox Foundation for Parkinson's Research
  • Hacettepe University

Zitieren

APA

Cinar, E., Yalcin-Cakmakli, G., Akyel, H., Ulusoy, A., Tel, B. C., & Elibol, B. (2025). Autophagy activation ameliorates cognitive deficits and alpha-synuclein pathology in an adeno-associated viral vector mediated rat model of Lewy body disorders. Pharmacology Biochemistry and Behavior. https://doi.org/10.1016/j.pbb.2025.174096

Vancouver

Cinar E, Yalcin-Cakmakli G, Akyel H, Ulusoy A, Tel BC, Elibol B. Autophagy activation ameliorates cognitive deficits and alpha-synuclein pathology in an adeno-associated viral vector mediated rat model of Lewy body disorders. Pharmacology Biochemistry and Behavior. 2025. doi:10.1016/j.pbb.2025.174096

BibTeX
@article{Cinar2025,
  author = {Cinar, Elif and Yalcin-Cakmakli, Gül and Akyel, Hilal and Ulusoy, Ayse and Tel, Banu Cahide and Elibol, Bülent},
  title = {Autophagy activation ameliorates cognitive deficits and alpha-synuclein pathology in an adeno-associated viral vector mediated rat model of Lewy body disorders},
  journal = {Pharmacology Biochemistry and Behavior},
  year = {2025},
  doi = {10.1016/j.pbb.2025.174096}
}
Kostenlos starten →